NeoGenomics (NEO) Earnings Date, Estimates & Call Transcripts $16.41 +0.01 (+0.06%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NeoGenomics Latest Earnings SummaryActual EPS (Nov. 5) $0.05 Beat By $0.04 Consensus EPS (Nov. 5) $0.01 NeoGenomics announced Q3 2024 earnings on November 5, 2024, reporting an EPS of $0.05, which beat analysts' consensus estimates of $0.01 by $0.04. Quarterly revenue rose 10.5% year-over-year to $167.80 million, above the consensus estimate of $167 million. With a trailing EPS of -$0.61, NeoGenomics' earnings are expected to grow next year, from ($0.16) to ($0.06) per share. Conference CallConference Call TranscriptEarnings Slide DeckSEC 10-Q/10-K FilingPowered by Get NeoGenomics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeoGenomics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNEO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NEO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. NeoGenomics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242-$0.13-$0.08-$0.11 Q2 20242-$0.11-$0.04-$0.08 Q3 20242-$0.08-$0.04-$0.06 Q4 20243-$0.07-$0.05-$0.06 FY 20249-$0.39-$0.21-$0.30 Q1 20252-$0.07-$0.03-$0.05 Q2 20252-$0.06-$0.02-$0.04 Q3 20252-$0.05-$0.01-$0.03 Q4 20251-$0.01-$0.01-$0.01 FY 20257($0.19)($0.07) ($0.13) NeoGenomics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/5/2024Q3 2024$0.01$0.05+$0.04$0.10$167.00M$167.80M7/29/2024Q2 2024-$0.0020$0.03+$0.0320$0.07$161.82M$164.50M4/30/2024Q1 2024-$0.07-$0.08 -$0.01$0.05$149.82M$156.24M2/20/2024Q4 2023-$0.07-$0.02+$0.05$0.07$152.90M$155.55M11/6/2023Q3 2023-$0.11-$0.06+$0.05$0.03$142.15M$151.95M8/8/2023Q2 2023-$0.15-$0.09+$0.06$0.01$138.22M$146.92M Get the Latest News and Ratings for NEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeoGenomics and its competitors with MarketBeat's FREE daily newsletter. 5/8/2023Q1 2023-$0.16-$0.13+$0.03-$0.01$126.31M$137.22M2/23/2023Q4 2022-$0.19-$0.10+$0.09-$0.02$129.96M$138.71M NeoGenomics Earnings - Frequently Asked Questions When did NeoGenomics announce their last quarterly earnings? NeoGenomics (NASDAQ:NEO) last announced its quarterly earning data on Tuesday, November 5, 2024. Learn more on NEO's earnings history. What guidance has NeoGenomics issued on next quarter's earnings? NeoGenomics updated its FY 2024 earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of 0.080-0.100 for the period, compared to the consensus EPS estimate of 0.060. The company issued revenue guidance of $655.0 million-$667.0 million, compared to the consensus revenue estimate of $661.7 million. Did NeoGenomics beat their earnings estimates last quarter? In the previous quarter, NeoGenomics (NASDAQ:NEO) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.04. Learn more on analysts' earnings estimate vs. NEO's actual earnings. How can I listen to NeoGenomics's earnings conference call? The conference call for NeoGenomics's latest earnings report can be listened to online. Listen to Conference Call How can I read NeoGenomics's conference call transcript? The conference call transcript for NeoGenomics's latest earnings report can be read online. Read Transcript How can I view NeoGenomics's earnings report? NeoGenomics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does NeoGenomics generate each year? NeoGenomics (NASDAQ:NEO) has a recorded annual revenue of $644.12 million. How much profit does NeoGenomics generate each year? NeoGenomics (NASDAQ:NEO) has a recorded net income of -$87.97 million. NEO has generated -$0.61 earnings per share over the last four quarters. What is NeoGenomics's EPS forecast for next year? NeoGenomics's earnings are expected to grow from ($0.16) per share to ($0.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies HealthEquity Earnings Date MARA Earnings Date Bilibili Earnings Date Etsy Earnings Date QXO Earnings Date Lyft Earnings Date Nuvei Earnings Date TriNet Group Earnings Date CarGurus Earnings Date DXC Technology Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW This page (NASDAQ:NEO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
